Additionally, it has been suggested that GGQLD could potentially alleviate non-alcoholic fatty liver disease (NAFLD) and hepatic steatosis by regulating inflammatory factors and oxidative stress through modulation of the NLRP3 signal axis [33]. This evidence concerns the gene NLRP3 and fatty liver disease.